PRICE T ROWE ASSOCIATES INC /MD/ - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 181 filers reported holding PTC THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.85 and the average weighting 0.7%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$24,706
-70.8%
1,102,445
-46.9%
0.00%
-66.7%
Q2 2023$84,470
+1.5%
2,076,934
+20.9%
0.01%0.0%
Q1 2023$83,210
+69.7%
1,717,765
+33.7%
0.01%
+50.0%
Q4 2022$49,025
-99.9%
1,284,389
-12.5%
0.01%
-33.3%
Q3 2022$73,654,000
+12.0%
1,467,193
-10.6%
0.01%
+50.0%
Q2 2022$65,738,000
+2.5%
1,640,986
-4.5%
0.01%
+33.3%
Q1 2022$64,116,000
-23.6%
1,718,458
-18.4%
0.01%
-25.0%
Q4 2021$83,904,000
+7.1%
2,106,561
+0.1%
0.01%
+14.3%
Q3 2021$78,329,000
-12.3%
2,105,060
-0.4%
0.01%
-12.5%
Q2 2021$89,302,000
-12.6%
2,112,668
-2.0%
0.01%
-20.0%
Q1 2021$102,128,000
-24.5%
2,156,874
-2.6%
0.01%
-28.6%
Q4 2020$135,182,000
+27.4%
2,215,017
-2.4%
0.01%
+16.7%
Q3 2020$106,100,000
-14.9%
2,269,517
-7.7%
0.01%
-25.0%
Q2 2020$124,741,000
+36.2%
2,458,426
+19.8%
0.02%
+14.3%
Q1 2020$91,577,000
-52.8%
2,052,837
-49.2%
0.01%
-44.0%
Q4 2019$193,945,000
+52.9%
4,037,987
+7.7%
0.02%
+38.9%
Q3 2019$126,809,000
-27.1%
3,749,518
-3.0%
0.02%
-25.0%
Q2 2019$174,028,000
+31.2%
3,867,289
+9.7%
0.02%
+20.0%
Q1 2019$132,664,000
+40.4%
3,524,542
+28.1%
0.02%
+25.0%
Q4 2018$94,457,000
-19.4%
2,752,246
+10.4%
0.02%
-5.9%
Q3 2018$117,161,000
+419.7%
2,492,785
+273.0%
0.02%
+466.7%
Q2 2018$22,544,000
+8188.2%
668,368
+7866.2%
0.00%
Q4 2015$272,0008,3900.00%
Other shareholders
PTC THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,750,000$84,053,0007.32%
RTW INVESTMENTS, LP 3,832,480$184,074,0006.94%
Burrage Capital Management LLC 195,725$9,401,0006.30%
Asymmetry Capital Management, L.P. 55,408$2,661,0004.77%
SECTORAL ASSET MANAGEMENT INC 328,738$15,789,0002.36%
ARMISTICE CAPITAL, LLC 758,000$36,407,0002.10%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 114,000$5,470,0001.97%
Opaleye Management Inc. 191,000$9,174,0001.80%
Sofinnova Investments, Inc. 517,092$24,836,0001.79%
Chubb Ltd 8,180$393,0001.68%
View complete list of PTC THERAPEUTICS INC shareholders